We are live on ! Find out more
BMO

Beck Mack & Oliver Portfolio holdings

AUM $4.85B
1-Year Est. Return 9.66%
This Fund
S&P 500
This Quarter Est. Return
+8.44%
1 Year Est. Return
+9.66%
3 Year Est. Return
+69.39%
5 Year Est. Return
+96.17%
10 Year Est. Return
+350.87%
AUM
$3.15B
AUM Growth
+$171M
Cap. Flow
-$50.7M
Cap. Flow %
-1.61%
Top 10 Hldgs %
39.38%
Holding
234
New
3
Increased
16
Reduced
102
Closed
4

Top Buys

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$69.5M
2
APO icon
Apollo Global Management
APO
+$21.5M
3
BB icon
BlackBerry
BB
+$7.83M
4
LUMN icon
Lumen
LUMN
+$5.06M
5
OAK
OAKTREE CAPITAL GROUP, LLC
OAK
+$1.86M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$20.2M
2
JEF icon
Jefferies Financial Group
JEF
+$15.3M
3
BAX icon
Baxter International
BAX
+$13.3M
4
LBTYA icon
Liberty Global Class A
LBTYA
+$12.6M
5
ABT icon
Abbott
ABT
+$6.71M

Sector Composition

Rank Sector Weight
1 Financials 29.01%
2 Healthcare 16.47%
3 Technology 12.09%
4 Communication Services 10.94%
5 Energy 10.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OAK
51
DELISTED
OAKTREE CAPITAL GROUP, LLC
OAK
$11.5M 0.36%
276,725
+45,155
+19% +$1.86M
AXS icon
52
AXIS Capital
AXS
$7.81B
$11.4M 0.36%
197,856
-2,968
-1% -$168K
MTB icon
53
M&T Bank
MTB
$36.3B
$11.1M 0.35%
67,446
-395
-0.6% -$68.5K
GSAT icon
54
Globalstar
GSAT
$10.1B
$10.1M 0.32%
1,322,569
-120,534
-8% -$901K
AAPL icon
55
Apple
AAPL
$4.97T
$9.05M 0.29%
160,380
-3,516
-2% -$183K
KMB icon
56
Kimberly-Clark
KMB
$37.6B
$8.61M 0.27%
75,755
-1,783
-2% -$200K
COP icon
57
ConocoPhillips
COP
$144B
$8.52M 0.27%
110,131
-916
-0.8% -$66.1K
RDNT icon
58
RadNet
RDNT
$4.98B
$7.76M 0.25%
515,520
-90,200
-15% -$1.29M
PG icon
59
Procter & Gamble
PG
$340B
$7.36M 0.23%
88,456
-5,286
-6% -$432K
ABBV icon
60
AbbVie
ABBV
$465B
$6M 0.19%
63,457
-950
-1% -$90.1K
CVX icon
61
Chevron
CVX
$382B
$5.65M 0.18%
46,191
-10,133
-18% -$1.23M
SJT
62
San Juan Basin Royalty Trust
SJT
$119M
$5.51M 0.18%
1,111,904
-207,616
-16% -$1.19M
BRK.A icon
63
Berkshire Hathaway Class A
BRK.A
$1.1T
$5.44M 0.17%
17
– –
FLR icon
64
Fluor
FLR
$6.54B
$5.19M 0.16%
89,307
-18,535
-17% -$1.01M
FISV
65
Fiserv Inc
FISV
$29.7B
$5.01M 0.16%
60,830
– –
HD icon
66
Home Depot
HD
$337B
$4.61M 0.15%
22,233
-1,000
-4% -$201K
PFE icon
67
Pfizer
PFE
$143B
$4.26M 0.14%
101,846
– –
MMM icon
68
3M
MMM
$91.8B
$3.96M 0.13%
22,480
-1,429
-6% -$246K
TV icon
69
Televisa
TV
$1.49B
$3.72M 0.12%
209,531
-12,620
-6% -$240K
OVV icon
70
Ovintiv
OVV
$17B
$3.69M 0.12%
56,298
-4,300
-7% -$279K
DVN icon
71
Devon Energy
DVN
$51.3B
$3.6M 0.11%
90,102
-42,353
-32% -$1.8M
CL icon
72
Colgate-Palmolive
CL
$74.8B
$3.59M 0.11%
53,659
-3,100
-5% -$206K
AZO icon
73
AutoZone
AZO
$51.3B
$3.49M 0.11%
4,500
– –
RTX icon
74
RTX Corp
RTX
$290B
$3.34M 0.11%
37,953
+794
+2% +$66.7K
BA icon
75
Boeing
BA
$169B
$3.26M 0.1%
8,769
+1,009
+13% +$354K
1 2
3
4 5

Similar funds

SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
MCCA
Mill Creek Capital Advisors Conshohocken, Pennsylvania $4.87B AUM 17.69% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
TPCW
TD Private Client Wealth New York $4.82B AUM 15.21% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
JSTA
Japan Science & Technology Agency Tokyo, Japan $4.81B AUM 4.62% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
KCM
Kensico Capital Management Greenwich, Connecticut $4.9B AUM 41.26% 1-Year Est. Return

Beck Mack & Oliver's Q3 2018 Portfolio in Review

As of Q3 2018, Beck Mack & Oliver held 234 positions worth $3.15B, up 5.7% from $2.98B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Trading was light in Q3 2018: portfolio turnover was 3%. Beck Mack & Oliver opened 3 new positions and exited 4, leaving the 234-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 29% of assets, up from 28% a quarter earlier, followed by Healthcare and Technology.

  • Beck Mack & Oliver's largest Q3 2018 buy was Teva Pharmaceuticals: 2,993,705 shares worth $64.5M.
  • Beck Mack & Oliver added most to Apollo Global Management in Q3 2018, an estimated $21.5M increase.
  • Beck Mack & Oliver's biggest Q3 2018 reduction was Merck, cutting an estimated $20.2M.
  • Beck Mack & Oliver fully exited JPMorgan Chase & Co. Depositary Shares, each representing a 1/400th interest in a share of 6.10% Non in Q3 2018, selling an estimated $211K.
  • Beck Mack & Oliver's ten largest holdings make up 39% of its $3.15B portfolio in Q3 2018.
  • Beck Mack & Oliver opened 3 new positions and closed 4 in Q3 2018.
  • Beck Mack & Oliver's portfolio value rose 5.7% quarter-over-quarter to $3.15B.

Based on Beck Mack & Oliver's 13F filing for Q3 2018, filed 29 Oct 2018.